Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial
新辅助西达胺联合化疗治疗激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者（MUKDEN 05）：一项多中心、单臂、II期临床试验
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101700
Xue, Jinqi; Shan, Huilian; Qiu, Fang; Niu, Nan; Chen, Guanglei; Xu, Qianshi; Gu, Xi; Xing, Fei; Xu, Yongqing; Zheng, Xinyu; He, Guijin; Xu, Hong; Zhang, Hao; Song, Dong; Han, Ye; Tang, Meiyue; Cao, Shuo; Song, Yang; Zheng, Ran; Zhao, Yafei; Jiao, Gege; Liu, Mingxin; Liu, Caigang
